Yikon Genomics Snares 220 Million Yuan in Series C Financing

According to Lieyunwang.com, Yikon Genomics, a provider of precision medical testing, has announced that it has got 220 million yuan in Series C financing, led by Jinhe Capital (a medical fund under the management of KingMed Diagnostics), with participation from Guangzhou Yuexiu Industrial Investment Fund, Hubei Zhongyuan Jiupai Industrial Investment, and BOCOM International Holdings. 

Proceeds in this financing will be used to further develop innovative products and services for reproductive genetics, maternal and child health, consolidate the leading position in the field of assisted reproduction, improve the effect of assisted reproduction therapy and prevent birth defects, and promote the development of the global reproductive health market.

Yikon Genomics is a leading solution-based single-cell sequencing company. Currently, based on the patented MALBAC® technology from Harvard University, Yikon Genomics provides complete solutions in the fields of reproductive health and cancer diagnostics with the liquid tumor biopsy. The MALBAC-PGS™ and MALBAC-PGD™ solutions offer the most accurate and comprehensive embryo testing results for physicians to choose the best embryos with balanced chromosomal copy numbers, without inheriting the known disease-associated alleles. These two kinds of solutions have helped thousands of couples to achieve successful pregnancies. 

Up to now, Yikon Genomics has successfully expanded its business to more than 20 countries, including the United States, the United Kingdom, Russia, Japan, Thailand, Malaysia, Cambodia. It has cooperated with famous reproductive medicine centers, such as New Hope, MFC, Genetix, Foundation Lab, CRHG and so on.

Founded in August 2011, Guangzhou Yuexiu Industrial Investment Fund is a corporate investment arm of Yue Xiu Enterprises (Holdings) Ltd. With a registered capital of 100 million yuan, the company manages funds of over 60 billion yuan. The company provides equity investment with market competitiveness. Besides, it has business covering real estate mezzanine and quantitative investment.

Zhongyuan Jiupai is an industrial fund jointly launched by listed company Zhongyuan, Hubei Provincial High Technology Industry Investment, and Jiupai Capital in October 2016. The company has established 6 equity investment funds of more than 1 billion yuan, among which 3 were invested by the Ministry of Science and Technology.